MedPath

Care for Late Stage Parkinsonism

Not Applicable
Completed
Conditions
Late Stage Parkinson's Disease
Parkinson's Disease
Interventions
Other: Specialist review
Registration Number
NCT02333175
Lead Sponsor
University College, London
Brief Summary

The aim of this project is to evaluate the needs and provision of care for patients in the late stages of Parkinsonism and their carers in several European countries, to compare the effectiveness of different health and social care systems, and to lay the foundation for improved outcomes in this population. The investigators will undertake an in-depth assessment of patients and their care arrangements in a population recruited through networks in six European countries. The systems and procedures that are used in the provision of care will be reviewed through a systematic literature review, interviews and assessments of patients, carers and health care providers, and through a trial comparing assessment by a specialist with management suggestions, guidance and access to telephone advice to that of usual care. Through interviews, questionnaire assessment and review of current health-care and social care arrangement, the investigators will assess the needs, provision of care and use of health-care resources, and their impact on patient and carer outcomes in different countries. National and regional databases will also be interrogated to identify current practice and use of healthcare resources and drug usage. A systematic literature review of the evidence for effective management strategies, analysis of the study data, and evaluation of change in outcomes following specialist review will provide the basis for recommendations in the management of late stage Parkinsonism. The investigators will also evaluate potentially useful outcome measures for use in this patient group. In addition to charting the needs and current care provision for late stage Parkinsonism in different European countries, its cost and effectiveness, and an analysis of health-care and social care predictors of improved outcome, the project will produce a platform for the assessment of patients with late stage Parkinsonism, their current treatment and care provision, as well as guidelines on the management of this late disease phase.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
184
Inclusion Criteria
  • Hoehn and Yahr stage (HY) IV or V in the "On"-state
  • Disease duration of at least 7 years
Exclusion Criteria
  • Symptomatic Parkinsonism

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Specialist reviewSpecialist reviewSpecialist review with individually tailored treatment strategies suggested by specialist
Primary Outcome Measures
NameTimeMethod
UPDRS-ADL part6 months

Disability measure

Secondary Outcome Measures
NameTimeMethod
Zarit carer burden scale6 months

Carer burden

Satisfaction with care Likert scale6 months
MMSE6 months

Mental health

NMSS6 months

PD severity

PDQ-8 or DEMQoL proxy6 months

Quality of Life

NPI6 months

Mental health

UPDRS III6 months

PD severity

Basic palliative care assessment6 months

ESAS-PD

PD milestones6 months

PD severity

Trial Locations

Locations (7)

Instituto de Medicina Molecular

🇵🇹

Lisbon, Portugal

University of Munich

🇩🇪

Munich, Bavaria, Germany

University of Bordeaux

🇫🇷

Bordeaux, France

University of Marburg

🇩🇪

Marburg, Germany

Radboud university medical center

🇳🇱

Nijmegen, Netherlands

Lund University

🇸🇪

Lund, Sweden

University College London

🇬🇧

London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath